Longfellow Investment Management’s Verona Pharma VRNA Stock Holding History

Longfellow Investment Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-713	Closed	-$76.1K	–	269
2025 Q3	$76.1K	Buy	+713	New	+$74.5K	0.02%	158

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Longfellow Investment Management's VRNA Position: Q4 2025 in Review

Longfellow Investment Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 713 shares — an estimated $76.1K sold.

Longfellow Investment Management first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $76.1K in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Longfellow Investment Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Longfellow Investment Management sold 713 Verona Pharma shares in Q4 2025, an estimated $76.1K.
Longfellow Investment Management first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Longfellow Investment Management's Verona Pharma position peaked at $76.1K in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Longfellow Investment Management's 13F filing for Q4 2025, filed 11 Feb 2026.